Biotronix Clinical Engineering announces the results of recent studies conducted by Nelson Laboratories. The studies tested the CTD Shield on Protective Standards for blood and micro biological viral penetration. The Nelson Laboratories’ studies confirm that the CTD Shield is an effective barrier in the prevention of the transfer of viruses and blood-borne pathogens. When used properly, the CTD Shield can play a vital role in developing a program designed to efficiently and effectively help reduce repairs, and cross-contamination risks associated with liquids, bodily fluids, blood-borne pathogens and microscopic viruses. Biotronix Clinical Engineering is committed to provide effective infection control solutions for the medical community. Click on the following links to view the Nelson Laboratory Results.

Viral Study

Blood Study

Health Releated Studies